Mr. Chair, I want to split my time with Ms. Gallant a little bit later.
First of all, I think I can assure Mr. Ouellet, the committee, and Canadians that there's no equivalency between the minor risks involved in mining uranium and the tremendous benefits that we've all experienced from nuclear power production and the medical treatments related to uranium. He can be assured of that.
I have two questions that I want to ask, and then I'll turn it over to Ms. Gallant.
Mr. Meyer, I was going to ask you what the new future is, as I asked last hour, but you've clearly laid that out. What I would like to know is where the resistance is to the shift in technology. When things move from something that's been done for 40 or 50 years to a new technology, where's the resistance there? Could you talk about that for a couple of minutes?
I'll actually ask my second question at the same time. Can you explain to us how a PET scanner actually functions? I think there's been some interest around the table, from what I've heard. Can you lay out how it actually works for us?